✦ LIBER ✦

Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas

✍ Scribed by Auriemma, R. S.; Pivonello, R.; Perone, Y.; Grasso, L. F. S.; Ferreri, L.; Simeoli, C.; Iacuaniello, D.; Gasperi, M.; Colao, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term cabergoline therapy is not ass

✍ Sophie Vallette; Karim Serri; Juan Rivera; Patricia Santagata; Sophie Delorme; N 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 165 KB

Severe mitral valve regurgitation with f

✍ M. Luedde; B. Helmke; H.A. Katus; N. Frey 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Rosiglitazone: Cardiac safety with long-

✍ Alan Salzman; KarenJ. Murphy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

2.282 The frequency of cardiac valve reg

✍ T. Sekiguchi; K. Kimura; H. Kishida; S. Koyano; Y. Baba; C. Kugimoto; T. Takahas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A comparison of cabergoline and bromocri

✍ Cesar Luiz Boguszewski; Carlos Mauricio Correa dos Santos; Kelly Suga Sakamoto; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 178 KB

Safety of long-term zolpidem treatment i

✍ Martin B. Scharf; Joseph Mendels; Michael Thorpy; Brian Weiss 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 712 KB